Showing results (1991-2000 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|March 8, 2016
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHDA Velasco-Guardado, A Mora-Soler, L López-Corral, et al.
Bone Marrow Transplantation|November 1, 1989
Stem cell self-renewal considerations in bone marrow transplantationP Mauch, J Ferrara, S Hellman
Bone Marrow Transplantation|November 1, 1989
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 monthsG C Yee, T R McGuire, B A St Pierre, et al.
Bone Marrow Transplantation|April 5, 2016
Impact of early CMV reactivation in cord blood stem cell recipients in the current eraM Ramanathan, P Teira, M Battiwalla, et al.
Bone Marrow Transplantation|April 5, 2016
How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCTS Fuji, A Rovó, K Ohashi, et al.
Bone Marrow Transplantation|August 8, 2017
Is there any role for physical therapy in chronic GvHD?J Mohammed, B N Savani, A El-Jawahri, et al.
Bone Marrow Transplantation|August 8, 2017
Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumorsJ A Guerra, G Dhall, A Marachelian, et al.
Bone Marrow Transplantation|June 14, 2016
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMTP Tsirigotis, M Byrne, C Schmid, et al.
Bone Marrow Transplantation|May 17, 2016
Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survivalK Sweiss, S Patel, K Culos, et al.
Bone Marrow Transplantation|May 17, 2016
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantationP Tsirigotis, I Danylesko, K Gkirkas, et al.
Pageof 993